English  |  正體中文  |  简体中文  |  總筆數 :0  
造訪人次 :  52886208    線上人數 :  879
教育部委託研究計畫      計畫執行:國立臺灣大學圖書館
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
關於TAIR

瀏覽

消息

著作權

相關連結

"lin y t"的相關文件

回到依作者瀏覽
依題名排序 依日期排序

顯示項目 721-730 / 1310 (共131頁)
<< < 68 69 70 71 72 73 74 75 76 77 > >>
每頁顯示[10|25|50]項目

機構 日期 題名 作者
臺大學術典藏 2020-08-13T06:33:26Z The Impact of Clinical Factors, ALK Fusion Variants, and BIM Polymorphism on Crizotinib-Treated Advanced EML4–ALK Rearranged Non-small Cell Lung Cancer Lin Y.-T.;Liu Y.-N.;Jin-Yuan Shih; Lin Y.-T.; Liu Y.-N.; JIN-YUAN SHIH
臺大學術典藏 2020-08-13T06:33:23Z MiR-200c-3p suppression is associated with development of acquired resistance to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in EGFR mutant non-small cell lung cancer via a mediating epithelial-to-mesenchymal transition (EMT) process Wang H.-Y.; Liu Y.-N.; Wu S.-G.; Hsu C.-L.; Chang T.-H.; Tsai M.-F.; Lin Y.-T.; JIN-YUAN SHIH; Wang H.-Y.;Liu Y.-N.;Wu S.-G.;Hsu C.-L.;Chang T.-H.;Tsai M.-F.;Lin Y.-T.;Jin-Yuan Shih
臺大學術典藏 2020-08-13T06:33:22Z Complex EGFR mutations with secondary T790M mutation confer shorter osimertinib progression-free survival and overall survival in advanced non-small cell lung cancer JIN-YUAN SHIH; Yu C.-J.; Liu Y.-N.; Wu S.-G.; Tsai T.-H.; Lin Y.-T.; Lin Y.-T.;Tsai T.-H.;Wu S.-G.;Liu Y.-N.;Yu C.-J.;Jin-Yuan Shih
臺大學術典藏 2020-08-13T05:24:02Z Outcome of untreated lung nodules with histological but no microbiological evidence of tuberculosis 11 Medical and Health Sciences 1103 Clinical Sciences Chung C.-L.; Chen Y.-F.; Lin Y.-T.; JANN-YUAN WANG; Kuo S.-W.; Chen J.-S.
臺大學術典藏 2020-08-12T08:25:24Z Development of renal cysts after crizotinib treatment in advanced ALK-positive non-small-cell lung cancer Lin Y.-T.; Wang Y.-F.; Yang J.C.-H.; Yu C.-J.; SHANG-GIN WU; Shih J.-Y.; Yang P.-C.
臺大學術典藏 2020-08-12T08:25:21Z Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor-sensitive Exon 19 Insertion and Exon 20 Insertion in Patients With Advanced Non-Small-cell Lung Cancer Lin Y.-T.;Liu Y.-N.;Shang-Gin Wu;Yang J.C.-H.;Shih J.-Y.; Lin Y.-T.; Liu Y.-N.; SHANG-GIN WU; Yang J.C.-H.; Shih J.-Y.
臺大學術典藏 2020-08-12T08:25:18Z MiR-200c-3p suppression is associated with development of acquired resistance to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in EGFR mutant non-small cell lung cancer via a mediating epithelial-to-mesenchymal transition (EMT) process Wang H.-Y.;Liu Y.-N.;Shang-Gin Wu;Hsu C.-L.;Chang T.-H.;Tsai M.-F.;Lin Y.-T.;Shih J.-Y.; Wang H.-Y.; Liu Y.-N.; SHANG-GIN WU; Hsu C.-L.; Chang T.-H.; Tsai M.-F.; Lin Y.-T.; Shih J.-Y.
臺大學術典藏 2020-08-12T08:25:17Z Complex EGFR mutations with secondary T790M mutation confer shorter osimertinib progression-free survival and overall survival in advanced non-small cell lung cancer Lin Y.-T.;Tsai T.-H.;Shang-Gin Wu;Liu Y.-N.;Yu C.-J.;Shih J.-Y.; Lin Y.-T.; Tsai T.-H.; SHANG-GIN WU; Liu Y.-N.; Yu C.-J.; Shih J.-Y.
臺大學術典藏 2020-08-12T07:47:00Z Transthoracic Ultrasound Elastography in Pulmonary Lesions and Diseases Lim C.-K.; Chung C.-L.; Lin Y.-T.; Chang C.-H.; Lai Y.-C.; HAO-CHIEN WANG; Yu C.-J.
臺大學術典藏 2020-08-12T06:34:19Z Clinical outcomes and secondary epidermal growth factor receptor (EGFR) T790M mutation among first-line gefitinib, erlotinib and afatinib-treated non-small cell lung cancer patients with activating EGFR mutations Lin Y.-T.;Chen J.-S.;Liao W.-Y.;Ho C.-C.;Hsu C.-L.;Yang C.-Y.;Chen K.-Y.;Lee J.-H.;Lin Z.-Z.;Shih J.-Y.;Yang J.C.-H.;Chong-Jen Yu; Ho C.-C.; Hsu C.-L.; Yang C.-Y.; Chen K.-Y.; Lee J.-H.; Lin Z.-Z.; Shih J.-Y.; Yang J.C.-H.; CHONG-JEN YU; Lin Y.-T.; Chen J.-S.; Liao W.-Y.

顯示項目 721-730 / 1310 (共131頁)
<< < 68 69 70 71 72 73 74 75 76 77 > >>
每頁顯示[10|25|50]項目